ONPATTRO conc perf 10 mg/5ml flac 5 ml
7680673040010
CH-67304
N07XX12
01.99.0.
Reimbursement limitations:
ONPATTRO_1
Dans le traitement en monothérapie de l’hATTR chez le patient symptomatique (score PND ≥ I …
1 / 3
google
Details
- Product number
- 6730401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- patisiranum 2 mg ut patisiranum natricum, DLin-MC3-DMA, 1,2-dimyristoyl-sn-glycero-3-carboxaminopropylmacrogoli 2000 aether methylicus, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, dinatrii phosphas heptahydricus, kalii dihydrogenophosphas, natrii chloridum, aqua ad iniectabile natrium 3.99 mg, q.s. ad solutionem pro 1 ml corresp..
Articles (1)
Onpattro 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.99 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 8466.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2020
Authorization holder
Alnylam Switzerland GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 67304
- Drug name
- Onpattro, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSPA
- ATC Code
- N07XX12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/09/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ONPATTRO conc perf 10 mg/5ml flac 5 ml
- Description (DE)
- ONPATTRO Inf Konz 10 mg/5ml Durchstf 5 ml
- Market launch
- 23/09/2019
- Narcotic (BTM)
- No
Application methods
IV